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List of abbreviations used for phospholipids and their charges 
 
 
Name Abbreviation  Charge 
Lysophosphatidic acid  LPA  negative 
Lysophosphocholine LPC  positive 
Phosphatidylinositol PI  negative 
Phosphatidylinositol-3-phosphate PI(3)P  negative 
Phosphatidylinositol-4-phosphate PI(4)P  negative 
Phosphatidylinositol-5-phosphate PI(5)P  negative 
Phosphatidylinositol-3,4-bisphosphate PI(3,4)P2 negative 
Phosphatidylinositol-3,5-bisphosphate PI(3,5)P2 negative 
Phosphatidylinositol-4,5-bisphosphate PI(4,5)P2 negative 
Phosphatidylinositol-3,4,5-triphosphate PI(3,4,5)P3 negative 
Phosphatidylethanolamine PE  neutral 
Phosphatidylcholine PC  neutral 
Sphingosine-1-phosphate SIP  negative 
Phosphatidic Acid  PA  negative 
Phosphatidylserine PS  negative 
 
 
 
 
 
 
 
 
 
 
  1Introduction 
Sorting nexin 9 (SNX9) belongs to a larger family of BAR-domain containing proteins 
(Habermann, 2004). It is characterized by an N-terminal Src homology 3 (SH3) domain, 
a phox homology (PX) domain, and a Bin/Amphiphysin/Rvs-homology (BAR) domain 
(Lundmark and Carlsson, 2003) (Figure 1). Together with clathrin and dynamin, it 
functions mainly in the endocytic pathway to sort proteins. (Worby and Dixon, 2002). 
SNX9 has also been shown to regulate receptor-mediated endocytosis of epidermal 
growth factor receptor (EGFR), by its interaction with Activated Cdc42-associated 
kinase-2 (ACK2) (Lin et al., 2002), thus implicating a role for SNX9 in signal 
transduction. 
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Figure 1. Schematic diagram of SNX9, showing the location of the SH3, PX, and BAR 
domains, and what each domain binds to. 
 
SNX9 and other Sorting nexin proteins bind to membranes via their PX and BAR 
domains. In SNX9, the PX domain is about 156 residues. The crystal structures of the PX 
domains for p40
phox (Bravo et al., 2001) and for Grd19p, a yeast homolog of human 
SNX3, (Zhou et al., 2003) have been solved. In both structures, the PX domain was 
complexed to phosphatidylinositol-3-phosphate (PI(3)P), thus revealing not only a 
tertiary structure consisting of β-sheets and α-helices (Figure 2A and 2B), but also a 
  2phosphatidylinositol phosphate-binding pocket. Based on the crystal structure and 
sequence alignments of the PX domain, at least two arginines are implicated in 
phospholipid binding. Thus, the PX domain is thought to recruit proteins to specific areas 
at cellular membranes by means of specific phosphatidylinositol binding.  
A                           B  
 
 
 
 
Figure 2. Crystal structures of the PX domain complexed to PI(3)P, which is portrayed as 
a ball-and-stick model. (A) PX domain of p40
phox (PDB entry 1H6H) (Bravo et al., 2001). 
(B) PX domain of Grb19p (PBD entry 1OCS) (Zhou et al., 2003). 
 
The BAR domain of SNX9, on the other hand, is about 205 residues and does not bind 
specific lipids. Instead, it binds membranes via electrostatic interactions. A close look at 
the crystal structure of the BAR domain of amphiphysin reveals a crescent-shaped dimer 
of six α-helices (Peter et al., 2004) (Figure 3A). The BAR domain is described as being 
both a sensor and an inducer of membrane curvature (Habermann, 2004). It not only 
binds preferentially to curved membranes, but also causes tubulation of vesicles in vitro 
(Peter et al., 2004 and Frasad et al., 2001). The crystal structure also suggests that a pair 
of helices and loops on the BAR domain inserts into the lipid bilayer, thus allowing it to 
bind membranes (Masuda et al., 2006) (Figure 3B).  
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Figure 3. The crystal structure of the BAR domain dimer reveals a six α-helix bundle. (A) 
BAR domain dimer of amphiphysin (PDB entry 1URU) (Peter et al., 2004). (B) A pair of 
helices and loops in the Endophilin-A1 BAR domain dimer (PDB entry 1ZWW) is 
believed to insert into the membrane bilayer to facilitate membrane binding. 
 
The specific cellular functions of the multi-domain protein SNX9 are also actively 
studied. In Drosophila Melanogaster and mammalian cells, SNX9 was found to interact 
with ACK2 and associate with clathrin and adaptor protein 2 (AP2), thus suggesting that 
SNX9 is involved in the formation of clathrin-coated pits (Lundmark and Carlsson, 2002). 
This finding helps to confirm the role of SNX9 in endocytosis. Besides interacting with 
SNX9 in clathrin-coated pits formation, ACK2 also phosphorylates SNX9. The 
phosphorylated SNX9 then proceeds to down-regulate EGF signaling by degradation of 
its receptor (Lin et al., 2002).  
Although the main cellular functions of SNX9 have been brought to light, little is known 
about the molecular mechanism by which this multi-domain protein participates in 
endocytosis and signaling. It is also unclear if and how the protein is regulated by 
membrane or protein binding. In the long term, we hope to understand the interactions 
between the various domains of SNX9 and how conformational changes might occur 
upon membrane binding. To this end, we have crystallized and solved the structure of a 
shorter construct of SNX9 (here after called SNX9
PX-BAR), which consists of the PX and 
  4BAR domains. This is the first solved structure of a BAR domain and an adjacent domain. 
By analyzing this multi-domain structure and by conducting lipid- and vesicle-binding 
assays, we are able to gain a better understanding of how the two domains interact to 
influence the membrane binding ability of SNX9.  
The structure of SNX9
PX-BAR shows a dimeric BAR domain that is moderately curved 
compared to other BAR domains, such as that of Endophilin and Amphiphysin. The BAR 
domain dimer interface has a buried surface area of 5697 Å
2 and is partially hydrophobic. 
Thus, the BAR domain of SNX9 forms stable dimers, via hydrophobic and some 
hydrophilic interactions on the membrane surface. Membrane binding is most likely 
driven by electrostatic interactions between the PX-BAR domain and the negatively-
charged membrane. Consequently, SNX9 might be localized to the plasma membrane to 
participate in early endocytosis. In addition, the PX domain of SNX9 shows high and 
specific binding affinity to PI(3)P. Therefore, we propose that the PX domain also helps 
to localize SNX9 to membranes with a high concentration of PI(3)P, such as in early 
endosomes and multivasicular bodies (Gillooly et al., 2000), thus implicating a role for 
SNX9 at the early endosome level. 
Results and Discussion 
Purification and crystallization of SNX9
PX-BAR
Purification of the native protein, using a combination of affinity chromatography and gel 
filtration, resulted in a highly pure sample of SNX9
PX-BAR with virtually no degradation 
or aggregation products (Figure 4A and 4B). The expression level was also reasonably 
high. During the purification process, it was observed that the protein had a high affinity 
  5for the matrix in the columns. This is probably due to the electrostatic interaction 
between the PX-BAR domain and the chromatography matrix. Therefore, a high salt 
buffer containing 400 mM NaCl was required in the desalting and gel filtration buffer to 
prevent the protein from binding to the columns. The pure sample of the native protein 
crystallized readily within 4 to 5 days to give both cuboidal and rod-shaped crystals 
(Figure 4C and 4D).  
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Figure 4. Purification and crystallization of native SNX9
PX-BAR protein. (A) 
Chromatogram showing UV absorbance of SNX9
PX-BAR as the protein passed through the 
gel filtration column. (B) Coomassie-stained gel of protein fractions, collected during gel 
filtration, reveals relatively pure SNX9
PX-BAR (about 40 kD). (C) Cuboidal crystals of 
native SNX9
PX-BAR protein. (D) Rod-shaped crystals of the same protein.  
 
  6However, the purification of selenomethionine-substituted SNX9
PX-BAR, using the His6-
tag expression system, resulted in low expression of the protein. As such, I switched to 
the His6-SUMO-tag expression system to purify selenomethionine-substituted SNX9
PX-
BAR protein. The resulting expression level was significantly higher (Figure 5A and 5B). 
In order to obtain experimental phases necessary for solving the crystal structure, I tried 
to crystallize the selenomethionine-substituted SNX9
PX-BAR. However, the protein did not 
crystallize readily and so seeding with the native cubiodal crystals was necessary. 
Seeding was optimized by diluting the seed stock in varying amounts of reservoir 
solution. This step is important for obtaining single large cubiodal crystals (Figure 5C) 
that possess good diffraction properties. 
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Figure 5. Purification and crystallization of selenomethionine-substituted SNX9
PX-BAR 
protein.  (A) Chromatogram showing UV absorbance of selenomethionine-substituted 
SNX9
PX-BAR as the protein passed through the gel filtration column. (B) Coomassie-
stained gel of protein fractions, collected during gel filtration, reveals relatively pure 
selenomethionine-substituted SNX9
PX-BAR (about 40 kD). (C) Cuboidal crystals of 
selenomethionine-substituted SNX9
PX-BAR protein obtained after seeding.  
  7Crystal structure of SNX9
PX-BAR  
Using the data set collected from the selenomethionine crystal, we determined the 
structure of SNX9
PX-BAR. This construct encompasses both the PX and BAR domains. 
The crystal diffracted X-rays to a maximum resolution of 2 Å. A representative 
diffraction pattern is shown in Figure 6A and the statistics for data collection, structure 
solution, and refinement are summarized in Table 1. Structure solution and refinement 
yielded a final Rwork value of 22.3 % and an Rfree value of 24.7 %. These values indicate a 
good agreement between the model and the original data. Figure 6B shows the crystal 
structure of SNX9
PX-BAR. The structure shows a dimeric BAR domain that is moderately 
curved and each BAR domain is made up of three α-helices. The PX domain is located at 
either side of the BAR domain dimer and is made up of α-helices and β-sheets. By 
comparing the BAR domain dimer of SNX9
PX-BAR to that of Endophilin A1 (Figure 6D), 
Bin 1 (Figure 6E), and Amphiphysin 1 (Figure 6F), I observe that the BAR domain dimer 
of SNX9
PX-BAR has the least curvature. 
Structure SNX9
PX-BAR (residues 230-595) 
Space Group  C2221 
Unit Cell  a=67.0 Å, b=144.0 Å, c=103.3 Å, α=β=γ=90° 
X-ray source  CHESS (beamline F2)  
Wavelength (Å)  0.97918 
Resolution (Å)  50 - 2.08 (2.15 - 2.08) 
Measured reflect. (#)  424,466 
Unique reflect. (#)  30,319 
I / σI  20.6 (9.6) 
Completeness (%)  100.0 (100.0) 
Rsym (%)  9.8 (31.6) 
 
 
 
 
 
  
  8  
Current Model Refinement Statistics 
Phasing  Single wavelength anomalous diffraction (SAD) 
Figure of merit (FOM)  0.46 (Solve)/0.69 (Resolve) 
Selenium sites found  14 (of 14) 
Molecules/AU 1 
Rwork / Rfree (%)
b 22.3 / 24.7 
aValues as defined in SCALEPACK (Otwinowski and Minor, 1997), CNS (Brünger et al., 1998) 
and SOLVE/RESOLVE (Terwilliger and Berendzen, 1999); 
bNo sigma cutoffs. 
 
Table 1. Summary of statistics for data collection, structure solution, and refinement. 
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Figure 6. Diffraction pattern and crystal structures of BAR domain proteins. (A) A 
representative diffraction pattern of SNX9
PX-BAR. (B) Crystal structure of SNX9
PX-BAR 
(top view). (C) Crystal structure of SNX9
PX-BAR (side view), showing slight curvature. (D) 
Crystal structure of Endophilin A1 (side view) (Gallop et al., 2005), showing more 
curvature. (E) Crystal structure of Bin 1 (side view) (Casal et al., 2006), showing greater 
curvature.  (F) Crystal structure of Amphiphysin 1 (side view) (Peter et al., 2004), 
showing greater curvature.  
  9Using the Crystallography and NMR System (CNS), I calculated the surface area of the 
protein that is buried in the SNX9
PX-BAR BAR domain dimer interface: 5697 Å
2. This 
value is very high, suggesting a strong interaction between the BAR domains. A 
summary of the residues involved in this interface is shown below (Table 2). There are 
more hydrophobic residues than hydrophilic residues in the interface, thus suggesting a 
strong hydrophobic interaction at the interface. Looking at the contact residues in the 
BAR domain dimer interface, I also identified eight residue pairs that are involved in 
hydrogen bonding (Table 3). This is done by setting a 3.2 Å maximum distance cut off 
between contact residues. These hydrogen bonds, together with the strong hydrophobic 
interactions at the interface, contribute to the stability and specificity of the SNX9
PX-BAR 
BAR domain dimer.  
Hydrophobic 
residues 
Hydrophilic 
residues  
64 36 
Table 2. Summary of hydrophobicity of residues buried in the SNX9
PX-BAR BAR domain 
dimer interface, based on Eisenberg hydrophobicity scale.  
 
Residue pairs involved in  
hydrogen bonding 
HIS    423     &    GLU  434 
GLU  434     &    ARG  426 
TYR  454     &    TYR  239 
GLU  457     &    ARG  559 
TYR  570     &    TYR  471 
GLN  574     &    TYR  471 
TYR  578     &    TYR  435 
GLU  579     &    ARG  586 
Table 3. Residue pairs, buried in the SNX9
PX-BAR BAR domain dimer interface, that are 
involved in hydrogen bonding. 
  10A look at the electrostatic potential on the concave and convex surfaces of SNX9
PX-BAR 
reveals that the concave side (Figure 7A) contains more patches of positively-charged 
residues than the convex side (Figure 7B). These positively-charged residues most likely 
facilitate the binding of SNX9
PX-BAR to a negatively-charged membrane surface, which 
might promote membrane curvature and endocytosis. 
A                               BBBB 
 
 
 
 
Figure 7. Electrostatic potential map of SNX9
PX-BAR dimer. (A)  Concave side of 
SNX9
PX-BAR dimer, showing more patches of positively-charged residues (blue). (B) 
Convex side of SNX9
PX-BAR dimer, showing more patches of negatively-charged residues 
(red). 
 
The BAR and PX interface has a buried surface area of 2308 Å
2. This suggests that the 
interaction between the two domains might be relatively strong. A summary of the 
residues involved in this interface is shown below (Table 4). The interface consists of 
both hydrophobic and hydrophilic residues, but appears more polar than the BAR dimer 
interface. There are also six residue pairs involved in hydrogen bonding (Table 5). These 
hydrogen bonds, together with the hydrophobic interactions at the interface, contribute to 
the interaction between the BAR and PX domains of SNX9
PX-BAR. 
  11Hydrophobic 
residues 
Hydrophilic 
residues  
22 20 
Table 4. Summary of hydrophobicity of residues buried in the PX-BAR domain interface 
of SNX9
PX-BAR, based on Eisenberg hydrophobicity scale.  
 
Residue pairs involved in 
hydrogen bonding 
TRP    243    &     GLU  551 
TYR   245    &     HIS    554 
ARG  330     &    GLU   491 
ARG  337     &    GLU   495 
ARG  337     &    ASP    562 
HIS    341     &    GLU   551 
Table 5. Residue pairs, buried in the PX-BAR domain interface of SNX9
PX-BAR, that are 
involved in hydrogen bonding. 
 
SNX9 binds specifically to PI(3)P  
There is some controversy over the binding of the PX domain to a specific phospholipid. 
In some classes of SNXs, such as SNX3 and SNX17, the PX domain has been shown to 
possess high affinity for PI(3)P (Czubayko et al., 2006 and Xu et al., 2001). However, in 
a recent paper by Badour et al., the PX domain of SNX9 was shown to have specific 
binding affinity for PI(3,4,5)P3, thus contradicting earlier reports. As such, I carried out a 
protein-lipid overlay assay, together with a number of negative controls, to seek out 
SNX9’s true phospholipid preference. I performed the assay simultaneously on each of 
the following proteins: SNX9 full length, SNX9
PX-BAR, SNX9 full length R286A/R318A 
mutant, and human Endophilin-A1 BAR domain.  
  12The results reveal that both SNX9 full length and SNX9
PX-BAR show high affinity to 
PI(3)P  (Figure 7). I also saw weaker binding of both SNX9 full length and SNX9
PX-BAR 
to PI(4)P, PI(5)P, PI(3,4)P2, PI(4,5)P2, and PA. Thus, SNX9 is likely to target specific 
membrane sites containing PI(3)P with highest affinity. The negative controls, including 
the double arginine mutant and the Endophilin BAR domain, do not show binding to any 
phospholipids. However, as protein-lipid overlay assays are known to be prone to false-
positive results, the binding of SNX9 to PI(3)P shall be confirmed by liposome binding 
assays (see below). 
                    
PC 
 
Figure 7. SNX9 and SNX9
PX-BAR show high affinity for PI(3)P. Endophilin BAR domain, 
SNX9, SNX9
PX-BAR, and SNX9 mutant proteins (all His6-tagged) were used to probe 
membranes spotted with different phospholipids. An antibody, recognizing the His6-tag, 
was used to detect binding of proteins to lipids.  
LPA 
LPC 
PI 
PI(3)P 
PI(4)P 
PI(5)P 
PE 
S1P 
PI(3,4)P2 
PI(3,5)P2 
PI(4,5)P2 
PI(3,4,5)P3 
PA 
PS 
Blank 
No 
protein 
Endophilin 
BAR 
SNX9   SNX9 
PX-BAR  
SNX9 
mutant  
 
Liposome binding assays 
To corroborate the results obtained from the protein-lipid overlay assay and to investigate 
the membrane binding affinity of SNX9 full length, I carried out vesicle binding assays. 
Here, I investigate the binding of SNX9 to vesicles made up of 100 % PC; 60 % PC and 
40 % PS; 95 % PC and 5 % PI(3)P; or 55 % PC, 40 % PS and 5 % PI(3)P. Human 
  13Endophilin-A1 BAR domain and Bovine Serum Albumin (BSA) were used as controls. 
The results of the negative control, BSA, show that the top three fractions contain protein 
bound to the vesicles, while the bottom three fractions contain unbound protein.  
                     BSA    Endophilin BAR                SNX9                       
Fraction                 1    2    3   4    5    6    7         1    2    3   4    5   6    7        1     2    3   4    5   6   7                         
    
 
 
 
PC/PS/PI(3)
PC/PS 
PC/PI(3)P 
PC 
Figure 8. SNX9 full length protein exhibits greatest binding affinity for vesicles 
containing PS and PI(3)P. BSA, Endophilin BAR domain, and SNX9 were incubated 
with 100nm vesicles of different compositions. The proteins and vesicles were 
centrifuged on sucrose gradients and fractions were removed from the top of the 
gradients. The top three fractions represent protein bound to the vesicles, while the 
bottom three fractions represent unbound protein.  
 
I observed that human Endophilin-A1 BAR domain exhibits greater binding affinity for 
vesicles containing 60 % PC and 40 % PS than vesicles with 100 % PC. This is due to the 
electrostatic interaction between the protein and the negatively-charged PS in the vesicles 
(Peter et al., 2004). The addition of PI(3)P increases the affinity of Endophilin-A1 BAR 
domain to membranes only weakly, as can be seen by comparing the band patterns for PC 
and PC/PI(3)P. This interaction might be due to the net negative charge of PI(3)P, rather 
than a specific interaction between the BAR domain and PI(3)P, as Endophilin did not 
bind to any specific lipid in the protein-lipid overlay assay. 
  14I was also able to show that SNX9 full length protein exhibits greater binding affinity for 
vesicles containing 60 % PC and 40 % PS than vesicles with 100 % PC. Since PC is 
uncharged and PS has a net negative charge, we can suggest that the patches of 
positively-charged residues on the concave surface of the BAR domain are essential for 
SNX9 to bind membranes. The addition of 5 % PI(3)P to the vesicles further increases 
the binding affinity of SNX9 full length to the vesicles. Thus, my results suggest that the 
PX domain of SNX9 binds specifically to PI(3)P and increases the binding affinity of 
SNX9 to membranes that have a high concentration of PI(3)P. The binding of SNX9 to 
PI(3)P might also help to localize the protein to membranes with a high concentration of 
PI(3)P, such as in early endosomes and multivasicular bodies.  
It will also be interesting to investigate whether the binding of the PX and BAR domains 
to membranes is cooperative or additive. From the visual inspection of the results, it 
appears that there is cooperativity between the PX and BAR domains of SNX9 in 
promoting membrane binding. However, future experiments using radiolabeled proteins 
need to be conducted to quantify the binding of SNX9 to vesicles of different 
compositions. Also, we would need to investigate the specificity of the PX domain in 
binding of phosphatidylinositols.  
SNX9
PX-BAR is phosphorylated by Src  
In 2002, Lin et al. showed that SNX9 is phosphorylated by ACK2. Recently, a graduate 
student in the Cerione lab mapped all the tyrosine phosphorylation sites on SNX9 upon 
incubation with ACK2 and Src. It was found that tyrosines 177, 239, 269, 294, and 561 
of SNX9 are phosphorylated by Src. This information is useful for us in our analysis of 
  15the crystal structure of SNX9
PX-BAR, since it allows us to predict the consequences of 
tyrosine phosphorylation. With reference to the crystal structure, tyrosine 239 is involved 
in hydrogen bond formation, while tyrosines 561 is involved in hydrophobic interaction 
at the BAR domain dimer interface. Therefore, it is plausible that the phosphorylation of 
these important tyrosines could affect dimer formation or protein conformation.  
As such, I did a phosphorylation assay on SNX9
PX-BAR using Src kinase to prove that the 
construct used for crystallization is capable of being phosphorylated. My results showed 
that active Src phosphorylates SNX9 full length and SNX9
PX-BAR  (Figure 9), thus 
confirming the results obtained by the Cerione lab. Our future goal is to investigate 
whether the phosphorylation state of SNX9 may affect its signaling capability, 
membrane-binding ability, and conformation.  
Time (min)      0     30    60    90   120   150              0    30    60    90   120  150              
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Figure 9. SNX9 full length and SNX9
PX-BAR is phosphorylated by active Src kinase. Each 
protein was incubated with active Src for a time course of 150 minutes. Reactions were 
quenched using SDS buffer. Phosphorylation was detected using an anti-phosphotyrosine 
(PY) specific antibody. Active Src is auto-phosphorylated. It also phosphorylates SNX9 
full length and SNX9
PX-BAR. In some cases, I observed a gradual increase in 
phosphorylation over time (right panel).  
 
Conclusion 
In short, the crystal structure of SNX9
PX-BAR reveals a stable, but moderately-curved BAR 
domain dimer that is held together mainly by hydrophobic interaction and some hydrogen 
bonding. The concave surface of the dimeric SNX9
PX-BAR has more patches of positively-
  16charged residues than the convex surface. Thus, the protein most likely binds to 
negatively-charged membranes, namely plasma membranes, by electrostatic interaction 
via its concave surface. My results agree with and corroborate previous studies that 
SNX9 is localized to the plasma membrane to participate in early endocytosis together 
with clathrin.  
However, my results also show that the PX domain of SNX9 binds strongly and rather 
specifically to PI(3)P. Thus, the PX domain might help to target the protein to 
membranes that have a high concentration of PI(3)P, for example early endosomes and 
multivesicular bodies. This result implies that SNX9 might work on endosomes to sort 
vesicles. Given these new insights, it will be interesting to expand our study of the 
cellular functions of SNX9, namely endocytosis and sorting of vesicles. Future studies 
should also include investigating the specificity of SNX9 in binding of 
phosphatidylinositols.   
In the long run, by studying the structure and function of SNX9, we hope to be able to 
elucidate the molecular mechanism by which SNX9 participates in endocytosis and 
regulates signaling pathways. In the process, we also hope to learn how the various 
domains of SNX9 interact with one another and contribute to protein regulation and 
changes in conformation.  
Materials and Methods 
All chemicals used in the lab are of the highest quality and are purchased from J. T. 
Baker. All media, unless otherwise specified, are purchased from Becton, Dickinson, and 
Company, and prepared with double-distilled water. Enzymes, unless otherwise specified, 
  17are purchased from New England Biolabs. Also, instruments and columns used for 
protein purification are from GE Healthcare. 
Protein expression and purification 
A short construct of SNX9 (SNX9
PX-BAR, residues 230-595) was cloned into a bacterial 
expression vector pProEx HTb (Invitrogen) using BamHI/NotI restriction sites. The 
vector encodes for a His6 tag, which will be fused to the N-terminal of the protein. The 
recombinant plasmid was transformed into Escherichia coli cells (BL21DE3, Novagen), 
which were then grown in large cultures of 5 to 6 liters of Terrific Broth (TB) media, 
supplemented with 100 mg/ml of Ampicillin. 1 mM of isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the cultures to induce protein production 
when the OD600 reading reached 1.0. Protein production took place at 18
oC for 16 hours.  
The bacterial cells were collected by centrifugation at 4000 x g for 1 hour, before being 
resuspended in NiNTA buffer A (125 mM Tris-base [pH 7.5], 2.5 M NaCl, 100 mM 
imidazole) containing 1% polyoxyethylene 20 sorbitan monolaurate (Tween) and frozen 
in liquid nitrogen. The resuspended cells were then subjected to a freeze-thaw cycle and 
lyzed using a sonicator. Centrifugation at 38,000 x g for 45 minutes separated the cell 
debris from soluble proteins. The supernatant, containing the soluble proteins, was loaded 
onto a NiNTA column that was equilibrated in NiNTA buffer A. After washing the resin 
with 20 column volumes of the same buffer to remove unspecific binding, the proteins 
were eluted on a gradient of 0 – 100 % NiNTA buffer B (1:1 volume of NiNTA buffer A 
and 1 M imidazole). Using a Fast Desalting Column, buffers were exchanged for 
desalting buffer (400 mM NaCl, 25 mM Tris-base [pH 7.5]). 
  18The His6-tag on the protein was removed by incubation with Precision Protease (GE 
Healthcare) and the cleaved proteins were collected in the flow through after the sample 
was passed through a second NiNTA column. Finally, the cleaved proteins were loaded 
onto a Superdex200 column, equilibrated in gel filtration buffer (400 mM NaCl, 25 mM 
Tris-base [pH 7.5], 1 mM DTT). The fractions containing our protein of interest were 
pooled and concentrated using a Amicon® Ultrafiltration Device (Millipore) to a final 
concentration of about 40 mg/ml. The concentrated protein was then frozen as aliquots in 
liquid nitrogen and stored at -80
oC.  
Selenomethionine-substituted protein expression and purification 
SNX9
PX-BAR (residues 230-595) was cloned into a bacterial expression vector pSUMO 
using BamHI/NotI restriction sites. The vector encodes for both His6 and SUMO tag, 
which will be fused to the N-terminal of the protein. The recombinant plasmid was 
transformed into Escherichia coli cells (B834, Novagen), which were grown in large 
cultures of 4 liters of M9 media supplemented with 2 mM MgSO4, 25 mg/l FeSO4, 0.4 % 
glucose, 40 mg/l of each amino acid (except Methionine), 40 mg/l Seleno-L-Methionine, 
1 mg/l vitamins, and 30 mg/ml of Kanamycin. 1 mM of IPTG was added to the cultures 
to induce protein production when the OD600 reading reached 0.6. Protein production 
took place at 18
oC for 16 hours.  
The purification of the selenomethionine-substituted protein was carried out according to 
the protocol for the native protein. 5 mM β-mercaptoethanol was added to all buffers, 
except the gel filtration buffer, in order to prevent oxidation of selenomethionine. 
Ubiquitin-like protein-specific protease (Ulp-1) was used, instead of Precision protease, 
  19to cleave off the His6-SUMO tag. The selenomethionine-substituted protein was then 
concentrated to about 40 mg/ml, frozen as aliquots in liquid nitrogen, and stored at -80
oC. 
Crystallization, X-ray data collection, and structure solution 
Crystals of native and selenomethionine-substituted SNX9
PX-BAR were obtained by 
hanging drop vapor diffusion with reservoir solution containing 1.8 M ammonium sulfate, 
0.1 M Tris-base (pH 8.5), 5 % PEG 400, 0.05 M MgSO4, and 15 % xylitol. Large 
cubiodal native crystals, with a typical dimension of 0.3 x 0.3 x 0.3 mm
3, appeared within 
4 to 5 days at 20°C. However, selenomethionine-substituted crystals were obtained by 
micro-seeding with native crystals using a cat whisker. The crystals were dipped in 100 
% paraffin oil and frozen in liquid nitrogen. 
Statistics for data collection, structure solution, and refinement are summarized in Table 
1. The selenomethionine-substituted crystals diffracted X-rays to 2 Å (space group: 
C2221). Each asymmetric unit consists of one molecule of SNX9
PX-BAR and each unit cell 
measures A = 67.0 Å, B = 144.0 Å, C = 103.3 Å, α = β = γ = 90°. Data sets were 
collected using synchrotron radiation of wavelength 0.97918 Å at CHESS, Cornell, 
beamline F2. The software SCALEPACK (Otwinowski and Minor, 1997) was used to 
process the data. The structure was determined using the experimental phases obtained 
from the selenomethionine-substituted crystals, and the phases were calculated using 
Single-wavelength Anomalous Dispersion (SAD). Structure solution was carried out 
using the software SOLVE/RESOLVE (Terwilliger and Berendzen, 1999), while 
structure refinement was carried out using Crystallography and NMR System (CNS) 
(Brünger et al., 1998). The final Rwork value is 22.3 % and the Rfree value is 24.7 %. 
  20Site-directed mutagenesis (SNX9 full length) 
Point mutations were introduced to replace two arginines in the SNX9 PX domain that 
are involved in phospholipid binding. The QuikChange® II XL Site-Directed 
Mutagenesis Kit (Stratagene) and mutant primers (Table 6) were used to generate the 
mutations in SNX9 full length protein. Following the instructions of the kit, I used Pfu 
ultra polymerase, enhanced by Quik Solution, to extend the plasmid by PCR. The 
resulting mutant protein contains the following mutations: R286A and R318A. This 
protein was then expressed and purified according to the protocol for wild-type proteins. 
The mutant protein had expression level comparable to that of wild-type protein.  
Primer Sequence  5’-3’ 
SNX9 R286A sense  CAC TAA TCG ATC TGT AAA CCA CGC GTA TAA 
GCA CTT TGA CTG GTT A 
SNX9 R286A anti-sense  TAA CCA GTC AAA GTG CTT ATA CGC GTG GTT 
TAC AGA TCG ATT AGT G 
SNX9 R318A sense  CCA GAC AAA CAA GTC ACA GGC GCC TTT GAA 
GAG GAA TTT ATC AAA ATG CG 
SNX9 R318A anti-sense  CGC ATT TTG ATA AAT TCC TCT TCA AAG GCG 
CCT GTG ACT TGT TTG TCT GG 
Table 6. List and sequences of sense and anti-sense primers used for site-directed 
mutagenesis. Primers were purchased from Elim Biopharmaceuticals, Inc. 
 
Protein-lipid overlay assay 
Protein-lipid overlay assays were conducted using PIP-Strips  (Echelon Research 
Laboratories), which are hydrophobic membranes that have been spotted with 100 pmol 
each of fifteen different lipids. The membrane was blocked with 3 % fatty-acid-free 
bovine serum albumin (Sigma) in PBS-T (PBS + 0.1 % Tween20) for one hour with 
gentle agitation at room temperature. Next, 0.5 μg/ml of protein (containing His  tag) was 
TM
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  21incubated with the blocked membrane for one hour at room temperature. The membrane 
was then washed three times with PBS-T for ten minutes each. The membrane was 
incubated with an anti-penta-His-specific primary antibody (1:5000, Qiagen), washed 
with PBS-T, incubated with anti-mouse alkaline phosphatase conjugated secondary 
antibody (1:5000, Jackson Immuno Research), and washed again with PBS-T. Finally, 
specific binding of protein to lipid was detected using CDP-star chemiluminescence 
reagent (PerkinElmer Life Sciences). Care was taken throughout the experiment to 
minimize exposure of the membranes to light.  
Liposome binding assay 
Specific amounts of L-α-Phosphatidylcholine (Egg, Chicken), L-α-Phosphatidylserine 
(Brain, Porcine), and PI(3)P, from Avanti Polar Lipids Inc., were mixed to form large 
unilamellar vesicles of the following desired concentrations: 100 % PC; 60 % PC and 40 
% PS; 55 % PC and 5 % PI(3)P; or 55 % PC, 40 % PS and 5 % PI(3)P. Chloroform was 
completely evaporated using a stream of nitrogen gas and desiccated under vacuum 
overnight. The resulting lipid film was suspended in a buffer containing 100 mM KCl 
and 25 mM Hepes (pH 7.4). The lipid suspension was then subjected to five freeze-thaw 
cycles and vigorous vortexing. Lastly, the suspension was extruded twenty-one times 
through a 100 nm polycarbonate membrane (Avestin, Inc.). 
200 µg of a specific composition of vesicles was incubated with 15 µg of protein (BSA, 
human Endophilin-A1 BAR domain, or SNX9 full length) and the reaction volume was 
made up to 25 µl using the above-mentioned buffer. The binding reaction was allowed to 
proceed for 1 hour at room temperature. Then, 75 µl of 67 % (w/w) sucrose dissolved in 
  22the above-mentioned buffer was added and 80 µl taken out and placed in the bottom of a 
250 µl ultracentrifuge tube. This was then overlaid with 90 µl of 40 % sucrose and 40 µl 
of 4 % sucrose. The sucrose gradient containing the protein and vesicles is then subjected 
to centrifugation at 87,000 rpm for 1 hour (Beckman, TLA-100 rotor). Next, 30 µl 
fractions were retrieved from the top of the sucrose gradient and ran on an SDS-
polyacrylamide gel. The gel was stained with Coomassie Brilliant Blue dye for 
visualization of the protein bands.  
Phosphorylation assay 
50 ng of active Src (Upstate Cell Signaling Solutions) was added to 1 µg of each protein, 
in a buffer solution containing 50 mM Tris-base (pH 7.4), 2 mM MgCl 10 mM MnCl , 
and 1 mM ATP. Phosphorylation reaction was allowed to take place for a time-course of 
150 minutes at 30 C. The reaction was quenched by SDS buffer. Samples were then run 
on SDS-polyacrylamide gel by electrophoresis. The proteins were transferred from the 
gel to a PVDF membrane (BioRad) at 40 mA for one hour. The membrane was blocked 
with 3 % fatty-acid-free bovine serum albumin in PBS-T overnight at 4 C. Subsequently, 
the membrane was incubated with anti-phosphotyrosine specific primary antibody 
(1:1000, Upstate Cell Signaling Solutions), washed with PBS-T, incubated with anti-
mouse alkaline phosphatase conjugated secondary antibody (1:5000), and washed again 
with PBS-T. Finally, phosphorylation of protein was detected using chemiluminescence 
reagent.  
2,  2
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